Gene Editing Market 2025 to 2034
Gene Editing Market 2025 to 2034
Gene Editing Market (By Product and Services: Reagents & Consumables, Software & Systems, Services; By Technology: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Transcription Activator-Like Effector Nuclease (TALEN), Zinc Finger Nuclease (ZFN), Antisense, Other technologies; By Application: Cell Line Engineering, Genetic Engineering, Drug Discovery & Development, Other Applications; By End-user: Pharmaceutical and Biotechnology Companies, Academic and Research Institutes; By Region: North America, Latin America, Europe, Asia-Pacific, Middle and East Africa) Industry Size, Share, Growth, Trends 2025 to 2034.
Customisation Request
Revenue, 2025
USD 10.77 Bn
Forecast Year, 2034
USD 40.10 Bn
CAGR, 2025 - 2034
15.74%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global gene editing market, valued at USD 10.77 billion in 2025, is projected to surge to USD 40.10 billion by 2034, growing at a CAGR of 15.74%, driven by advances in biotechnology and increasing adoption across healthcare and research sectors.
Gene Editing Market Size Analysis
Gene Editing Market Size By Product and Services 2025 to 2034 (USD Billion)
| Product and Services | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Software & Systems | 2.38 | 2.76 | 3.19 | 3.69 | 4.27 | 4.95 | 5.73 | 6.63 | 7.67 | 8.88 |
| Services | 3.35 | 3.87 | 4.48 | 5.19 | 6.00 | 6.95 | 8.04 | 9.31 | 10.77 | 12.47 |
| Reagents & Consumables | 5.04 | 5.84 | 6.75 | 7.82 | 9.05 | 10.47 | 12.12 | 14.03 | 16.23 | 18.79 |
Gene Editing Market Size By Technology 2025 to 2034 (USD Billion)
| Technology | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Other technologies | 1.01 | 1.17 | 1.36 | 1.57 | 1.82 | 2.10 | 2.43 | 2.82 | 3.26 | 3.77 |
| Antisense | 1.11 | 1.28 | 1.48 | 1.72 | 1.99 | 2.30 | 2.66 | 3.08 | 3.57 | 4.13 |
| Zinc Finger Nuclease (ZFN) | 1.42 | 1.64 | 1.90 | 2.20 | 2.55 | 2.95 | 3.41 | 3.95 | 4.57 | 5.29 |
| Transcription Activator-Like Effector Nuclease (TALEN) | 1.72 | 1.99 | 2.31 | 2.67 | 3.09 | 3.57 | 4.14 | 4.79 | 5.54 | 6.41 |
| Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) | 5.51 | 6.38 | 7.38 | 8.54 | 9.88 | 11.44 | 13.24 | 15.33 | 17.74 | 20.53 |
Gene Editing Market Size By Application 2025 to 2034 (USD Billion)
| Application | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Other Applications | 1.11 | 1.29 | 1.49 | 1.73 | 2.00 | 2.31 | 2.68 | 3.10 | 3.59 | 4.15 |
| Genetic Engineering | 2.57 | 2.97 | 3.44 | 3.98 | 4.61 | 5.34 | 6.18 | 7.15 | 8.27 | 9.58 |
| Cell Line Engineering | 2.94 | 3.40 | 3.93 | 4.55 | 5.27 | 6.10 | 7.06 | 8.17 | 9.46 | 10.95 |
| Drug Discovery & Development | 4.15 | 4.80 | 5.56 | 6.43 | 7.45 | 8.62 | 9.98 | 11.55 | 13.36 | 15.47 |
Gene Editing Market Size By End-user 2025 to 2034 (USD Billion)
| End-user | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Academic and Research Institutes | 3.70 | 4.28 | 4.95 | 5.73 | 6.64 | 7.68 | 8.89 | 10.29 | 11.91 | 13.78 |
| Pharmaceutical and Biotechnology Companies | 7.07 | 8.18 | 9.47 | 10.96 | 12.69 | 14.69 | 17.00 | 19.67 | 22.77 | 26.36 |
Gene Editing Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Middle East and Africa | 0.56 | 0.65 | 0.75 | 0.87 | 1.01 | 1.17 | 1.35 | 1.56 | 1.81 | 2.09 |
| Latin America | 0.78 | 0.90 | 1.04 | 1.20 | 1.39 | 1.61 | 1.86 | 2.16 | 2.50 | 2.89 |
| Asia Pacific | 2.51 | 2.90 | 3.36 | 3.89 | 4.50 | 5.21 | 6.03 | 6.98 | 8.08 | 9.35 |
| Europe | 2.79 | 3.23 | 3.74 | 4.33 | 5.01 | 5.80 | 6.72 | 7.78 | 9.00 | 10.42 |
| North America | 4.13 | 4.78 | 5.53 | 6.40 | 7.41 | 8.57 | 9.92 | 11.49 | 13.29 | 15.39 |
Gene Editing Market Size to Worth USD 40.10 Billion by 2034
The global gene editing market size was calculated at USD 10.77 billion in 2025 and is predicted to attain around USD 40.10 billion by 2034 a CAGR of 15.74%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
